Global Non-PVC IV Bags Market Size (2024 - 2029)

Non-PVC IV Bags Market Analysis

The Non-PVC IV Bags Market is expected is anticipated to grow with a CAGR of 5.5% during the forecast period (2022 - 2027).

The COVID-19 pandemic had a significant impact on the healthcare systems, with significant consequences not only for COVID-19-infected patients but also for others, resulting in the cancellation of treatment services. As per the article published in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that during the COVID-19 pandemic, there was a 46% decrease in the diagnoses of the six most common cancer types - breast, colorectal, lung, pancreatic, gastric, and esophageal cancers. Thus, the decreasing diagnosis and treatment have impacted the demand for non-PVC IV bags.

The factors that are attributed to the market growth are the increasing natality rate, the environment-friendly nature of non-PVC IV bags, and increasing government initiatives.

In addition, there is an increasing demand for non-PVC IV bags in the treatment of oncology, mainly for chemotherapy and targeted drug delivery as most of the therapeutic agents are susceptible to interactions with plasticizers and have a propensity to transform into harmful agents.

Non-PVC IV bags helps in minimizing the risk associated with conventional IV bags such as difficulty in transportation, and the interaction of drugs with the packaging material and disposable containers. Thus, the advantages offered by the PVC-free IV bags increase the demand for using non-PVC Iv bags thus shifting the company's focus on manufacturing PVC-free bags which is expected to increase the market growth. For instance,

The rising prevalence of cancer among the population is expected to increase the market growth over the forecast period. For instance, according to the January 2022 update by Breastcancer.org, about 1 in 8 United States women (about 13%) will develop invasive breast cancer throughout their lifetime. In addition, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the United States as compared to an estimated 276,480 new breast cancer cases occurred in 2020. Additionally, as per GLOBOCAN 2020 fact sheet,18.3% of new cases of cancers were reported in India in 2020, out of which cervical cancer accounted for 9.4% of all cancers. As per the same source, 300 114 new cancer cases in males were reported in Brazil in 2020, out of which 97 278 cases were of prostate cancer. In addition, 292 098 new cancer cases in females were reported in Brazil, in 2020. This is expected to increase the demand for PVC-free IV bags as cancer treatment deprives the human body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, which increases the demand for delivering parenteral nutrition to the patients, thereby propelling the market growth. Thus, the aforementioned factors are expected to increase market growth over the forecast period.

In addition, the growing burden of chronic diseases such as cardiovascular diseases, respiratory diseases and others are expected to increase the market growth. For instance, as per the article titled 'Evolution of Heart Surgery' published in June 2021, in the United States, heart disease is the top cause of death for both men and women. In 2020, about 500,000 open heart surgeries are carried out in the year. Therefore, the increasing requirement for cardiac surgeries ultimately increases the demand for non-PVC IV bags for transporting fluids, thereby propelling the market growth. Also, according to World Health Organization (WHO), 2022 updates, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide and nearly 90% of COPD deaths occur among people under 70 years of age in low- and middle-income countries (LMIC). This is expected to increase the demand for administering intravenous fluids after cardiac surgery and for patients treated for acute exacerbations which is anticipated to increase the demand for non-PVC IV bags, thereby boosting the market growth.

However, the high cost of non-PVC IV bags is likely to hinder the market growth over the forecast period.

Non-PVC IV Bags Industry Segmentation

As per the scope of the report, non-PVC IV bags are intravenous bags that are made up of non-polyvinyl chloride film. These bags have several advantages such as less pollution, safety, compatibility, lightweight, convenience, and low risk of contamination due to which there is a huge demand for oncology treatment. The Non-PVC IV Bags Market is segmented By Material (Ethylene Vinyl Acetate, Copolyester ether, Polypropylene, and Others), Product (Multi-Chamber, Single Chamber), Content (Liquid Mixture and Frozen Mixture), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.